Daniel possesses extensive experience in representing companies in a wide range of international commercial transactions, with an emphasis on mergers and acquisitions, financing transactions and sophisticated technology transfer arrangements.
Daniel provides counsel on a variety of commercial fields, including technology licensing transactions, domestic and international R&D grants, distribution and manufacturing agreements, capital raising, complex joint ventures, sale of assets and privacy protection.
In addition, Daniel manages the firm’s activities in the field of options and employee equity incentives. In this framework, Daniel counsels startups, technology companies, and senior managers on all aspects of designing and implementing capital incentive plans and individual grants for employees and senior executives.
Daniel’s clients include venture capital funds, investors, industrial companies, and startups in various fields – medical devices, augmented and virtual reality, internet, fintech etc.
The Interdisciplinary Center Herzliya (LL.B, B.A Business Administration), 2009
Member of Israel Bar Association since 2010
News and updates - Daniel Lorber:
How Israel Became a Leader in the FoodTech Industry?
FoodTech is an industry implementing agrifood technologies which covers a broad range of fields in the food and beverage value and chain supply chain, including, the development of the next generation of food and beverages, improving the efficiency of agricultural crops, maintaining food and beverage fresh for longer periods, food and beverage safety, nutrition and sports as well as supply and sales platforms for food and beverage consumers.
In Israel, over 200 startups and companies are at the forefront of innovation in the field. In addition, two technology incubators are operating in the central and northern parts of the country with the aim of identifying and developing early stage startups in the field.
Foreign venture capital funds and international food companies recognize the great value of Israeli innovation and are active in making investments and collaborating for the development of new Israeli products.
Representing Sartorius in the acquisition of a majority stake in Biological Industries.
Our firm represented Sartorius, a leading multinational corporation in the field of life science, research and development and biopharmaceutical industry, in a transaction to acquire a majority stake in the Israeli cell culture developer Biological Industries. Sartorius acquired the majority of Biological Industries shares by way of secondary purchase of shares from the Development Company of Kibbutz Beit Haemek and private equity fund Fortissimo Capital, in consideration for USD 50 million. In addition, as part of the transaction, Sartorius and the Development Company of Kibbutz Beit Haemek signed an option to purchase/sell additional holdings in the future.
Representing German Fund Mercura in Investment in Israeli Startup 3DSignals
Our firm represented the German fund Mercura in its investment in 3DSignals. This Israeli startup enables the monitoring of production floor performance. The investment follows the company's rapid growth in the German market.